OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
OPKO Health (Nasdaq: OPK) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference, scheduled for December 3-5, 2024, at the Lotte New York Palace Hotel in New York City.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OPKO Health (Nasdaq: OPK) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference, scheduled for December 3-5, 2024, at the Lotte New York Palace Hotel in New York City. The company's management will engage in one-on-one meetings with investors and participate in a fireside chat on December 4th at 1:30 p.m. Eastern time. The session will be webcast live and available for replay through OPKO Health's website's Investors section.
Details
News Market Reaction – OPK
The recorded move for OPK in the trading session of this news was -2.47%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Nov. 20, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 36th Annual Healthcare Conference, being held December 3-5, 2024 at the Lotte New York Palace Hotel in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, December 4th at 1:30 p.m. Eastern time.
The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.